Clinical trial
Intact Potential Symptoms and Biomarker Analysis in Diagnosis of Acid Sphingomyelinase Deficiency (ASMD)
NCT07274826 is registered in ClinicalTrials.gov with Sohag University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intact Potential Symptoms and Biomarker Analysis in Diagnosis of Acid Sphingomyelinase Deficiency (ASMD)
- Lead sponsor
- Sohag University
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- November 20, 2025
- Completion date
- September 10, 2026
- Enrollment
- 7 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acid sphingomyelinase deficiency (asmd)